NeuroSense Therapeutics NRSN Estimates

NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT
Analyst Estimates

NeuroSense Therapeutics Ltd. Revenue Estimates

Periods 15
Next Period Q2 27
Consensus 0.00

Analysts expect NeuroSense Therapeutics Ltd. to report revenue of 0.00 for Q2 27, against a range of 0.00 to 0.00.

Metric Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) --------
High Estimate 0.000.000.00667,207.233.34 M3.19 M3.11 M3.67 M
Low Estimate 0.000.000.00619,630.272.74 M2.72 M2.71 M3.14 M
Consensus Estimate 0.000.000.00643,418.753.04 M2.95 M2.91 M3.40 M
Analyst Estimates

NeuroSense Therapeutics Ltd. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q1 26
Consensus -1.59

Analysts expect NeuroSense Therapeutics Ltd. to report earnings per share of -1.59 for Q1 26, against a range of -1.71 to -1.47. The most recent reported quarter, Q2 26, came in at -3.90, a 4.6% beat against the -4.09 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -2.40-0.80-2.19-2.75-0.80-4.70--3.90-------
High Estimate -1.92-3.06-1.88-3.95-0.76-1.26-1.47-3.87-0.78-3.70-0.98-4.36-1.56-3.52-1.86
Low Estimate -2.32-3.28-2.16-4.65-0.90-1.48-1.71-4.31-0.88-3.96-1.04-4.80-1.68-4.20-2.16
Consensus Estimate -2.12-3.17-2.02-4.30-0.83-1.37-1.59-4.09-0.83-3.83-1.01-4.58-1.62-3.86-2.01

NeuroSense Therapeutics Ltd. Estimates API

Pull Wall Street consensus for NeuroSense Therapeutics Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=NRSN&mode=revenue&api_key=YOUR_API_KEY